The Anti‐RAS Cancer Drug MKT‐077 Is an F‐Actin Cross‐Linker
- 1 December 1999
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 886 (1) , 283-284
- https://doi.org/10.1111/j.1749-6632.1999.tb09437.x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Role of Phosphatidylinositol 4,5-Bisphosphate in Ras/Rac-Induced Disruption of the Cortactin-Actomyosin II Complex and Malignant TransformationMolecular and Cellular Biology, 1998
- Development of an enzyme-linked immunosorbent assay (ELISA) for antitumor agent MKT 077Analytica Chimica Acta, 1998
- Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with alpha-actinin cDNA.Proceedings of the National Academy of Sciences, 1993
- Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA.The Journal of cell biology, 1992